Unknown

Dataset Information

0

Oxidized low-density lipoprotein inhibits the degradation of cyclophilin A via the lysosome in vascular smooth muscle cells.


ABSTRACT: BACKGROUND:Cyclophilin A (CyPA) plays an important role in the progression of atherosclerosis. Additionally, it has been reported that lysosomal function is markedly impaired in atherosclerosis induced by oxidized low-density lipoprotein (ox-LDL). As the CyPA degradation pathway remains to be elucidated, we aimed to uncover the role of lysosomes and ox-LDL in the degradation of CyPA. METHODS:We exploited RNA interference (RNAi) in combination with either the lysosomal inhibitor chloroquine (CQ) or the proteasomal inhibitor MG-132 to examine CyPA turnover. We also investigated the role of ox-LDL in lysosomal function and the CyPA degradation pathway and determined whether CyPA interacts with the selective autophagy adaptor p62. RESULTS:CQ markedly reversed the CyPA downregulation induced by RNAi and increased intracellular levels of LC3 and p62. MG-132 significantly suppressed polyubiquitinated protein degradation but did not inhibit RNAi-induced CyPA downregulation. Additionally, neither CQ nor MG-132 influenced the gene-silencing efficiency of CyPA siRNA. Moreover, ox-LDL induced cytosolic accumulation of p62 was inconsistent with increased expression of LC3-II. Meanwhile, ox-LDL inhibited RNAi-induced downregulation of CyPA. Immunofluorescence indicated colocalization of endogenous CyPA with ubiquitin and with p62 in response to CQ treatment, and co-immunoprecipitation analysis confirmed interaction between CyPA and p62. CONCLUSION:CyPA is degraded by a lysosome-dependent pathway that may involve p62-mediated selective autophagy. Furthermore, ox-LDL modulates the degradation of CyPA via its inhibitory role in lysosomes, contributing to increased expression of CyPA in atherosclerotic plaques.

SUBMITTER: Su Z 

PROVIDER: S-EPMC7407676 | biostudies-literature | 2020

REPOSITORIES: biostudies-literature

altmetric image

Publications

Oxidized low-density lipoprotein inhibits the degradation of cyclophilin A via the lysosome in vascular smooth muscle cells.

Su Zizhuo Z   Lin Maohuan M   Su Yinqing Y   Li Jiajie J   Lin Rongjie R   Wu Maoxiong M   Wang Xiaoyu X   Huang Lili L   Chen Yuyang Y   Shu Xiaorong X   Liang Shumin S   Zhang Haifeng H   Huang Tucheng T   Nie Ruqiong R   Wang Jingfeng J   Xie Shuanglun S  

American journal of translational research 20200715 7


<h4>Background</h4>Cyclophilin A (CyPA) plays an important role in the progression of atherosclerosis. Additionally, it has been reported that lysosomal function is markedly impaired in atherosclerosis induced by oxidized low-density lipoprotein (ox-LDL). As the CyPA degradation pathway remains to be elucidated, we aimed to uncover the role of lysosomes and ox-LDL in the degradation of CyPA.<h4>Methods</h4>We exploited RNA interference (RNAi) in combination with either the lysosomal inhibitor ch  ...[more]

Similar Datasets

| S-EPMC8340951 | biostudies-literature
| S-EPMC5554480 | biostudies-other
| S-EPMC7710548 | biostudies-literature
| S-EPMC4882225 | biostudies-literature
| S-EPMC3475437 | biostudies-literature
| S-EPMC3995878 | biostudies-literature
| S-EPMC4114343 | biostudies-literature
| S-EPMC2775430 | biostudies-literature
| S-EPMC7447304 | biostudies-literature
| S-EPMC1135732 | biostudies-other